UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

Expert review of vaccines, 2017-01, Vol.16 (1), p.55-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Nature communications, 2022-07, Vol.13 (1), p.3840-3840, Article 3840

2022

Link zum Volltext

Verfügbarkeit prüfen

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

Cell reports (Cambridge), 2021-10, Vol.37 (1), p.109773-109773, Article 109773

2021

Link zum Volltext

Verfügbarkeit prüfen

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

Seminars in immunology, 2018-10, Vol.39, p.14-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

Frontiers in immunology, 2017-08, Vol.8, p.943-943

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Expert review of vaccines, 2018-07, Vol.17 (7), p.619-634

2018

Link zum Volltext

Verfügbarkeit prüfen

CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01

Frontiers in immunology, 2021-01, Vol.11, p.606805-606805

2021

Link zum Volltext

Verfügbarkeit prüfen

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

Frontiers in immunology, 2024-01, Vol.14, p.1279003-1279003

2024

Link zum Volltext

Verfügbarkeit prüfen

Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19

Frontiers in immunology, 2023-03, Vol.14, p.1107156-1107156

2023

Link zum Volltext

Verfügbarkeit prüfen

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

Frontiers in immunology, 2017-05, Vol.8, p.557-557

2017

Link zum Volltext

Verfügbarkeit prüfen

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design

npj vaccines, 2023-03, Vol.8 (1), p.34-34, Article 34

2023

Link zum Volltext

Verfügbarkeit prüfen

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Frontiers in immunology, 2023, Vol.14, p.1155200-1155200

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

npj vaccines, 2021-05, Vol.6 (1), p.78-78, Article 78

2021

Link zum Volltext

Verfügbarkeit prüfen

Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis

Frontiers in immunology, 2022-05, Vol.13, p.841009-841009

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

Expert review of vaccines, 2012-03, Vol.11 (3), p.349-366

2012

Link zum Volltext

Verfügbarkeit prüfen

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action

Frontiers in immunology, 2019-09, Vol.10, p.2150-2150

2019

Link zum Volltext

Verfügbarkeit prüfen

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e1037-e1045

2022

Link zum Volltext

Verfügbarkeit prüfen

Co-administration of COVID-19 and influenza vaccines

Clinical microbiology and infection, 2023-05, Vol.29 (5), p.558-559

2023

Link zum Volltext

Verfügbarkeit prüfen

The how's and what's of vaccine reactogenicity

npj vaccines, 2019-09, Vol.4 (1), p.39-39, Article 39

2019

Link zum Volltext

Verfügbarkeit prüfen

Towards an evidence based approach for the development of adjuvanted vaccines

Current opinion in immunology, 2017-08, Vol.47, p.93-102

2017

Link zum Volltext

Verfügbarkeit prüfen

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop

Preventive medicine reports, 2023-10, Vol.35, p.102331-102331, Article 102331

2023

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1920-1930

2014

Link zum Volltext

Verfügbarkeit prüfen

Commentary on "Common Vaccines and the Risk of Dementia: A Population-Based Cohort Study": Science Can be Messy but Eventually Leads to Truths

The Journal of infectious diseases, 2023-05, Vol.227 (11), p.1224-1226

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 - A Comprehensive Analysis

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

Co-administration of COVID-19 and influenza vaccines

The how's and what's of vaccine reactogenicity

Towards an evidence based approach for the development of adjuvanted vaccines

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Commentary on "Common Vaccines and the Risk of Dementia: A Population-Based Cohort Study": Science Can be Messy but Eventually Leads to Truths

Suchergebnisse filtern